Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), ISIN INE09XN01023 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AKUMS last traded at ₹768.00 (+4.50%), with a 52-week range of ₹409.30 to ₹838.80 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 75.26%, FIIs 4.50%, DIIs 11.09%, mutual funds 7.58%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.